MedPath
PPB Approval

TAZVERIK TABLETS 200MG

HK-68216

Prescription only Medicines

May 1, 2024

Company Information

Company Details

18/F, THE METROPOLIS TOWER, 10 METROPOLIS DRIVE, HUNG HOM, KOWLOON

Active Ingredients

tazemetostat (as hydrobromide)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TAZVERIK TABLETS 200MG - PPB 批准文号 | MedPath